Childhood cancer survivors at increased risk of sarcoma

	Tweet

Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma - a cancer of connective or supportive tissue such as bone, fat, or muscle - compared with the general population, according to a study in the February 21 Journal of the National Cancer Institute.

Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population. Previous studies have shown that these survivors are specifically at a higher risk of secondary sarcomas, such as soft tissue sarcomas and osteosarcoma. Radiation therapy is associated with secondary sarcomas, but other specific risk factors are largely unknown.

Tara Henderson, M.D., of the University of Chicago Department of Pediatrics, and colleagues examined the incidence of secondary sarcomas and the risk factors associated with that risk among the 14,372 participants in the Childhood Cancer Survivor Study. Overall, there were 751 second cancers diagnosed among the participants, 108 of which were secondary sarcomas such as soft tissue sarcoma, malignant peripheral nerve sheath tumors, and osteosarcoma. These sarcomas were diagnosed an average of 11 years after patients were diagnosed with their primary cancer.

The authors found that patients with secondary sarcomas were more likely to have received primary radiation therapy; to have received higher doses of drugs called anthracyclines or alkylators; to have had a primary diagnosis of soft tissue sarcoma, bone tumor, or Hodgkin lymphoma; to have a family history of cancer; or to have a history of other second cancers. The risk of a secondary sarcoma was ninefold higher among childhood cancer survivors than the general population. The authors calculated that the excess number of cases of secondary sarcomas among childhood cancer survivors over those in the general population is 32.5 cases per 100,000 person-years of follow-up.

“As the childhood cancer survivor population ages and expands in number, clinicians and researchers must carefully identify patients who are at risk for secondary morbidities, particularly for secondary cancers,” the authors write. “Diagnosis of a sarcoma can sometimes be elusive because symptoms are often nonspecific.”
###

EMBARGOED FOR RELEASE: 20 FEBRUARY 2007 16:00 ET
Contact: Liz Savage

301-841-1287
Journal of the National Cancer Institute

RELATED STORIES:
Cancer patients rarely speak up about care problems   Repeat imaging in kids with cancer: a balancing act   Exposing cancer more quickly   Music-based “Play” Helps Young Cancer Patients Cope   Biomarkers Allow Doctors to Match Therapy to Patient   Research Into Natural Killer Immune Cells Offers Avenues for Childhood Cancer Treatment   Persons Who Survive Cancer More Likely to be Unemployed   Dense tissue promotes aggressive cancers   Scientists develop new approach for cancer vaccine   Medical costs of cancer have nearly doubled over the past 2 decades   Scientists announce new advance with potential for future cancer targeting   Controlling for size may also prevent cancer   Reversing cell division has implications for the treatment of cancer   Harmless soil-dwelling bacteria successfully kill cancer   European downturn seen pushing up cancer rates   Bacteria could make new library of cancer drugs that are too complex to create artificially   Cancer survivors may not be getting the help they need to stop smoking   Children’s Cancer Group Recommends Global Evaluation System for Neuroblastoma to Improve Treatment   Radiation Treatment Prolonged Liver Cancer Patients’ Lives   Virus Attack on Cancer   Amgen drug slows bone loss in cancer patients   Discovery of a new mechanism of gene control that is associated with cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]